| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Moore David Scott is a Director at CRVS. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $250K at current prices.
Moore David Scott's largest disclosed position is in CRVS as Director, worth about $250K. Net of sales, the recent Form 4 record there shows accumulation of 21,700 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | CRVS Corvus Pharmaceuticals, Inc. | Director | Buy | 21,700 | $11.53 | $250,235.72 | New |